Clinical and laboratory study
The effects of chronic sunscreen use on the histologic changes of dermatoheliosis,☆☆

https://doi.org/10.1016/0190-9622(95)90284-8Get rights and content

Abstract

Background: Sunscreen application to the skin of hairless mice is effective in reversing the histologic changes associated with photoaging (solar elastosis, epidermal thickening, collagen depletion, glycosaminoglycan deposition). These reparative processes have not been studied in human beings.

Objective: The aim of this study was to evaluate histologically the effects of daily application of a UVAUVB sunscreen versus placebo.

Methods: We examined 46 patients who were given either sunscreen or vehicle and asked to apply it daily for 24 months. Punch biopsy specimens were obtained from preauricular skin at 0, 12 and 24 months. Each specimen was examined for epidermal thickening and organization and dermal inflammatory infiltrate by light microscopy. Computer-generated analysis of tissue sections was used to evaluate solar elastosis.

Results: A significant difference in solar elastosis was found between the treatment groups; however, the other features remained largely unchanged.

Conclusion: The dermal changes of photoaging may be affected differently than epidermal changes when UV radiation exposure is diminished. UVA and UVB may contribute diversely to these cutaneous changes. Computer-generated evaluation of dermatoheliosis may be more accurate than visual inspection.

Cited by (81)

  • Photoaging and Topical Rejuvenation

    2023, Clinics in Plastic Surgery
  • Photoaging and Topical Rejuvenation

    2022, Facial Plastic Surgery Clinics of North America
    Citation Excerpt :

    There are currently no guidelines for visible light protection, and as iron oxide is not an Food and Drug Administration (FDA) approved inorganic filter, it is listed as an inactive ingredient on sunscreen labels. There is high-quality evidence that daily sunscreen prevents of photoaging.14,15 A study including 903 adults randomized to daily sunscreen application versus discretionary sunscreen application tracked participants over 4.5 years.

  • Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection

    2017, Journal of the American Academy of Dermatology
  • Update on tanning: More risks, fewer benefits

    2014, Journal of the American Academy of Dermatology
  • The efficacy and safety of sunscreen use for the prevention of skin cancer

    2021, CMAJ
    Citation Excerpt :

    Une liste des ingrédients des écrans solaires actuellement approuvés par Santé Canada se trouve au tableau 110. Selon des données probantes tirées d’études d’observation11, d’un volumineux essai randomisé et contrôlé (ERC)12 et de petites études expérimentales non randomisées13-15, les écrans solaires préviendraient efficacement les signes de photovieillissement, y compris les rides, la télangiectasie et les anomalies pigmentaires induites par les rayons ultraviolets11-15. Malgré les difficultés auxquelles se bute la recherche sur le cancer de la peau, en raison de sa pathogenèse multifactorielle et de son évolution parfois lente, les données suivantes appuient le recours aux écrans solaires pour la prévention du cancer de la peau.

  • The efficacy and safety of sunscreen use for the prevention of skin cancer

    2020, CMAJ
    Citation Excerpt :

    The sunscreen ingredients that are currently approved by Health Canada are listed in Table 1.10 Evidence from observational studies,11 a large randomized controlled trial (RCT)12 and smaller, nonrandomized experimental studies13-15 support the effectiveness of sunscreens in preventing the signs of photoaging, including wrinkles, telangiectasia and pigmentary alterations induced by ultraviolet radiation.11-15 Despite the challenges of studying skin cancer, owing to its multifactorial pathogenesis and long lead time, the following evidence supports the use of sunscreen in the prevention of skin cancer.

View all citing articles on Scopus

Support for this project was provided by Westwood-Squibb Pharmaceuticals, Inc.

☆☆

Presented in poster form at the Thirty-second Annual Meeting of the American Society for Dermatopathology, New Orleans, Feb. 1–3, 1995.

View full text